Bionical Emas Sells EMAS Pharma To Kester Capital Following Strategic Review

(MENAFN - GlobeNewsWire - Nasdaq) Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute